nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—TNF—dilated cardiomyopathy	0.559	1	CbGaD
Pranlukast—ABCC2—Spironolactone—dilated cardiomyopathy	0.177	0.594	CbGbCtD
Pranlukast—ABCC2—Furosemide—dilated cardiomyopathy	0.121	0.406	CbGbCtD
Pranlukast—CYP2C9—cardial valve—dilated cardiomyopathy	0.00533	0.572	CbGeAlD
Pranlukast—Candesartan—AGTR1—dilated cardiomyopathy	0.00355	1	CrCbGaD
Pranlukast—NFKB1—myocardium—dilated cardiomyopathy	0.00161	0.173	CbGeAlD
Pranlukast—NFKB1—heart—dilated cardiomyopathy	0.00113	0.121	CbGeAlD
Pranlukast—NFKB1—cardiac atrium—dilated cardiomyopathy	0.000964	0.103	CbGeAlD
Pranlukast—CYP2C9—heart—dilated cardiomyopathy	0.000295	0.0316	CbGeAlD
Pranlukast—TNF—Allograft Rejection—FAS—dilated cardiomyopathy	0.000216	0.00167	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—LMNA—dilated cardiomyopathy	0.000216	0.00167	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—RAF1—dilated cardiomyopathy	0.000216	0.00166	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—RAC1—dilated cardiomyopathy	0.000215	0.00166	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—FASLG—dilated cardiomyopathy	0.000213	0.00165	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—RAF1—dilated cardiomyopathy	0.000213	0.00164	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—GJA1—dilated cardiomyopathy	0.000213	0.00164	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	0.000212	0.00164	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000212	0.00163	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000211	0.00163	CbGpPWpGaD
Pranlukast—NFKB1—BCR signaling pathway—RAF1—dilated cardiomyopathy	0.00021	0.00162	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00021	0.00162	CbGpPWpGaD
Pranlukast—NFKB1—Hair Follicle Development: Induction (Part 1 of 3)—EGFR—dilated cardiomyopathy	0.00021	0.00162	CbGpPWpGaD
Pranlukast—TNF—Ceramide signaling pathway—RAF1—dilated cardiomyopathy	0.000209	0.00162	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—CD36—dilated cardiomyopathy	0.000208	0.00161	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—FAS—dilated cardiomyopathy	0.000206	0.00159	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000204	0.00158	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—RAC1—dilated cardiomyopathy	0.000202	0.00156	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.000202	0.00156	CbGpPWpGaD
Pranlukast—NFKB1—TWEAK Signaling Pathway—TNF—dilated cardiomyopathy	0.0002	0.00154	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000199	0.00154	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000198	0.00153	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—PSEN2—dilated cardiomyopathy	0.000198	0.00153	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000195	0.0015	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—AGT—dilated cardiomyopathy	0.000193	0.00149	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—ITGB1—dilated cardiomyopathy	0.000193	0.00149	CbGpPWpGaD
Pranlukast—NFKB1—Leptin signaling pathway—RAF1—dilated cardiomyopathy	0.000192	0.00148	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.00019	0.00147	CbGpPWpGaD
Pranlukast—TNF—Cardiac Hypertrophic Response—RAF1—dilated cardiomyopathy	0.000188	0.00145	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—RAC1—dilated cardiomyopathy	0.000188	0.00145	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—CD36—dilated cardiomyopathy	0.000186	0.00143	CbGpPWpGaD
Pranlukast—NFKB1—TNF receptor signaling pathway —TNF—dilated cardiomyopathy	0.000186	0.00143	CbGpPWpGaD
Pranlukast—NFKB1—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000186	0.00143	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000184	0.00142	CbGpPWpGaD
Pranlukast—NFKB1—Ceramide signaling pathway—TNF—dilated cardiomyopathy	0.000179	0.00139	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—RAC1—dilated cardiomyopathy	0.000177	0.00137	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—RAF1—dilated cardiomyopathy	0.000176	0.00136	CbGpPWpGaD
Pranlukast—NFKB1—Angiopoietin receptor Tie2-mediated signaling—TNF—dilated cardiomyopathy	0.000174	0.00134	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000173	0.00133	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000173	0.00133	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—RAC1—dilated cardiomyopathy	0.000173	0.00133	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.000172	0.00133	CbGpPWpGaD
Pranlukast—NFKB1—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	0.000171	0.00132	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000169	0.0013	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—RAF1—dilated cardiomyopathy	0.000166	0.00128	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis-related network due to altered Notch3 in ovarian cancer—TNF—dilated cardiomyopathy	0.000166	0.00128	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—RAC1—dilated cardiomyopathy	0.000166	0.00128	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—RAF1—dilated cardiomyopathy	0.000165	0.00127	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—CD36—dilated cardiomyopathy	0.000164	0.00127	CbGpPWpGaD
Pranlukast—NFKB1—TGF-beta Receptor Signaling—TNF—dilated cardiomyopathy	0.000163	0.00126	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	0.000163	0.00126	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—RAF1—dilated cardiomyopathy	0.000163	0.00126	CbGpPWpGaD
Pranlukast—TNF—Downstream signaling in naïve CD8+ T cells—RAF1—dilated cardiomyopathy	0.000162	0.00125	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000161	0.00125	CbGpPWpGaD
Pranlukast—NFKB1—Cardiac Hypertrophic Response—TNF—dilated cardiomyopathy	0.000161	0.00124	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—FASLG—dilated cardiomyopathy	0.000161	0.00124	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000161	0.00124	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00016	0.00124	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000157	0.00121	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000157	0.00121	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Receptor Signaling Pathway—RAF1—dilated cardiomyopathy	0.000156	0.00121	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000156	0.0012	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000156	0.0012	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—FAS—dilated cardiomyopathy	0.000155	0.0012	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—RAC1—dilated cardiomyopathy	0.000155	0.0012	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.000154	0.00119	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—RAC1—dilated cardiomyopathy	0.000152	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—EGFR—dilated cardiomyopathy	0.00015	0.00116	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000149	0.00115	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000149	0.00115	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000146	0.00113	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—EGFR—dilated cardiomyopathy	0.000146	0.00113	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000146	0.00113	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—RAC1—dilated cardiomyopathy	0.000146	0.00113	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000145	0.00112	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—FAS—dilated cardiomyopathy	0.000145	0.00112	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—EGFR—dilated cardiomyopathy	0.000144	0.00111	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—RAF1—dilated cardiomyopathy	0.000144	0.00111	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of Telomerase—EGFR—dilated cardiomyopathy	0.000143	0.0011	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000141	0.00109	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00014	0.00108	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00014	0.00108	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TNF—dilated cardiomyopathy	0.000139	0.00107	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000137	0.00106	CbGpPWpGaD
Pranlukast—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000136	0.00105	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—AGT—dilated cardiomyopathy	0.000136	0.00105	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—RAC1—dilated cardiomyopathy	0.000135	0.00104	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—RAF1—dilated cardiomyopathy	0.000134	0.00103	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000133	0.00103	CbGpPWpGaD
Pranlukast—NFKB1—Signaling events mediated by HDAC Class I—TNF—dilated cardiomyopathy	0.000133	0.00102	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—FASLG—dilated cardiomyopathy	0.000131	0.00101	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00013	0.001	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000128	0.000985	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000127	0.000977	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000127	0.000977	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000126	0.000974	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—FAS—dilated cardiomyopathy	0.000126	0.000973	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—RAF1—dilated cardiomyopathy	0.000124	0.00096	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000124	0.000958	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000124	0.000958	CbGpPWpGaD
Pranlukast—NFKB1—Transcriptional regulation of white adipocyte differentiation—TNF—dilated cardiomyopathy	0.000123	0.000949	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—FASLG—dilated cardiomyopathy	0.000123	0.000946	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—SOD2—dilated cardiomyopathy	0.000121	0.000934	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000121	0.000932	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000119	0.000917	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—FAS—dilated cardiomyopathy	0.000118	0.000912	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000118	0.000909	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—RAC1—dilated cardiomyopathy	0.000116	0.000895	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—GPX1—dilated cardiomyopathy	0.000115	0.000891	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000115	0.000891	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—TNF—dilated cardiomyopathy	0.000115	0.000885	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TNF—dilated cardiomyopathy	0.000115	0.000885	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000115	0.000884	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.000114	0.000881	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000113	0.00087	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000113	0.00087	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000112	0.000862	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000111	0.000854	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	0.00011	0.000853	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000107	0.000823	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—TNF—dilated cardiomyopathy	0.000107	0.000823	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000105	0.000809	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000105	0.000807	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000104	0.000806	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—RAF1—dilated cardiomyopathy	0.000103	0.000793	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000101	0.000783	CbGpPWpGaD
Pranlukast—IL5—Immune System—ITGB1—dilated cardiomyopathy	0.000101	0.00078	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	0.000101	0.000779	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.0001	0.000774	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—RAC1—dilated cardiomyopathy	9.94e-05	0.000767	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—TNF—dilated cardiomyopathy	9.82e-05	0.000758	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	9.79e-05	0.000756	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—PSEN2—dilated cardiomyopathy	9.72e-05	0.000751	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—RAF1—dilated cardiomyopathy	9.67e-05	0.000747	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.54e-05	0.000737	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.35e-05	0.000722	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.27e-05	0.000716	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.27e-05	0.000716	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	9.1e-05	0.000703	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.05e-05	0.000699	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—RAC1—dilated cardiomyopathy	8.89e-05	0.000686	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.66e-05	0.000669	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.62e-05	0.000666	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD36—dilated cardiomyopathy	8.62e-05	0.000666	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—AGT—dilated cardiomyopathy	8.49e-05	0.000656	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	8.44e-05	0.000651	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.35e-05	0.000645	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.22e-05	0.000635	CbGpPWpGaD
Pranlukast—IL5—Immune System—RAC1—dilated cardiomyopathy	8.12e-05	0.000627	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—ITGB1—dilated cardiomyopathy	7.98e-05	0.000616	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	7.93e-05	0.000612	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—RAF1—dilated cardiomyopathy	7.68e-05	0.000593	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—dilated cardiomyopathy	7.66e-05	0.000592	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—EGFR—dilated cardiomyopathy	7.53e-05	0.000581	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.5e-05	0.000579	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.13e-05	0.000551	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.03e-05	0.000542	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—EGFR—dilated cardiomyopathy	6.99e-05	0.00054	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	6.99e-05	0.00054	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	6.95e-05	0.000536	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	6.93e-05	0.000535	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	6.92e-05	0.000534	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—CD36—dilated cardiomyopathy	6.81e-05	0.000526	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ITGB1—dilated cardiomyopathy	6.77e-05	0.000523	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ADRB2—dilated cardiomyopathy	6.77e-05	0.000522	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.71e-05	0.000518	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—RAF1—dilated cardiomyopathy	6.7e-05	0.000517	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.66e-05	0.000514	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.66e-05	0.000514	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—EGFR—dilated cardiomyopathy	6.63e-05	0.000512	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—RAF1—dilated cardiomyopathy	6.59e-05	0.000509	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TNF—dilated cardiomyopathy	6.59e-05	0.000508	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—RAC1—dilated cardiomyopathy	6.42e-05	0.000495	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.38e-05	0.000493	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	6.24e-05	0.000482	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.19e-05	0.000478	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—EGFR—dilated cardiomyopathy	6.14e-05	0.000474	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.1e-05	0.000471	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—ITGB1—dilated cardiomyopathy	6.08e-05	0.00047	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CD36—dilated cardiomyopathy	6.01e-05	0.000464	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	5.99e-05	0.000463	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	5.94e-05	0.000459	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—RAF1—dilated cardiomyopathy	5.9e-05	0.000455	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	5.81e-05	0.000449	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD36—dilated cardiomyopathy	5.78e-05	0.000446	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—RAC1—dilated cardiomyopathy	5.67e-05	0.000438	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—RAC1—dilated cardiomyopathy	5.44e-05	0.00042	CbGpPWpGaD
Pranlukast—IL5—Immune System—RAF1—dilated cardiomyopathy	5.39e-05	0.000416	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—EGFR—dilated cardiomyopathy	5.27e-05	0.000407	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RAC1—dilated cardiomyopathy	5.25e-05	0.000405	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—CD36—dilated cardiomyopathy	5.19e-05	0.000401	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.12e-05	0.000395	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—AGT—dilated cardiomyopathy	5.02e-05	0.000387	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—RAC1—dilated cardiomyopathy	4.89e-05	0.000377	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.86e-05	0.000375	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	4.75e-05	0.000367	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—EGFR—dilated cardiomyopathy	4.52e-05	0.000349	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—RAF1—dilated cardiomyopathy	4.26e-05	0.000329	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.24e-05	0.000328	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.23e-05	0.000327	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.17e-05	0.000322	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ITGB1—dilated cardiomyopathy	4.11e-05	0.000317	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.04e-05	0.000312	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.77e-05	0.000291	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.77e-05	0.000291	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.77e-05	0.000291	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—RAF1—dilated cardiomyopathy	3.76e-05	0.00029	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	3.76e-05	0.00029	CbGpPWpGaD
Pranlukast—IL5—Immune System—EGFR—dilated cardiomyopathy	3.69e-05	0.000285	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—RAF1—dilated cardiomyopathy	3.61e-05	0.000279	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—AGT—dilated cardiomyopathy	3.6e-05	0.000278	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	3.53e-05	0.000273	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.5e-05	0.00027	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD36—dilated cardiomyopathy	3.5e-05	0.00027	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RAF1—dilated cardiomyopathy	3.48e-05	0.000269	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.39e-05	0.000262	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—RAC1—dilated cardiomyopathy	3.3e-05	0.000255	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—RAF1—dilated cardiomyopathy	3.24e-05	0.00025	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	3.19e-05	0.000247	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EGFR—dilated cardiomyopathy	2.92e-05	0.000225	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.9e-05	0.000224	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.9e-05	0.000224	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—dilated cardiomyopathy	2.78e-05	0.000215	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.75e-05	0.000212	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EGFR—dilated cardiomyopathy	2.58e-05	0.000199	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.57e-05	0.000198	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.5e-05	0.000193	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	2.48e-05	0.000191	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—EGFR—dilated cardiomyopathy	2.47e-05	0.000191	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EGFR—dilated cardiomyopathy	2.39e-05	0.000184	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.36e-05	0.000182	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	2.33e-05	0.00018	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EGFR—dilated cardiomyopathy	2.22e-05	0.000172	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—RAF1—dilated cardiomyopathy	2.19e-05	0.000169	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.13e-05	0.000165	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	2.11e-05	0.000163	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—AGT—dilated cardiomyopathy	2.04e-05	0.000157	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.95e-05	0.00015	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.9e-05	0.000147	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.71e-05	0.000132	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	1.71e-05	0.000132	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EGFR—dilated cardiomyopathy	1.5e-05	0.000116	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.42e-05	0.000109	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EGFR—dilated cardiomyopathy	9.7e-06	7.49e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	8.68e-06	6.7e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	8.45e-06	6.52e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	7.61e-06	5.87e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.72e-06	4.42e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	5.57e-06	4.3e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	5.02e-06	3.87e-05	CbGpPWpGaD
